Trial Profile
A Study to Evaluate the Immunogenicity and Safety of a Trivalent Inactivated (2010 - 2011) Influenza Vaccine in Taiwan Infants.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record